Chronic Pain Video

Possible Alternatives to Opioids for Managing Chronic Neuropathic Pain

Possible Alternatives to Opioids for Managing Chronic Neuropathic Pain

Researchers from the University of Texas at Austin, Dallas, and Miami have made a revolutionary work in treating neuropathic pain. Neuropathic pain is the leading cause of high-impact chronic pain and affects approximately 10% of the population . Neuropathic pain occurs when the nervous system is damaged or malfunctions. This is one of the more challenging types of pain to relieve and difficult to treat.

1. Yousuf, M. S., Sahn, J. J., Yang, H., David, E. T., Shiers, S., Mancilla Moreno, M., … & Price, T. J. (2023). Highly specific σ2R/TMEM97 ligand FEM-1689 alleviates neuropathic pain and inhibits the integrated stress response. Proceedings of the National Academy of Sciences, 120(52), e2306090120.

2. A. Alon et al., Identification of the gene that codes for the sigma2 receptor. Proc. Natl. Acad. Sci. U.S.A. 114, 7160–7165 (2017).

3. J. J. Sahn, G. L. Mejia, P. R. Ray, S. F. Martin, T. J. Price, Sigma 2 Receptor/Tmem97 agonists produce long lasting antineuropathic pain effects in mice. ACS Chem. Neurosci. 8, 1801–1811 (2017).

4. A. Alon et al., Structures of the sigma2 receptor enable docking for bioactive ligand discovery. Nature 600, 759–764 (2021).

5. G. Cassano et al., F281, synthetic agonist of the sigma-2 receptor, induces Ca2+ efflux from the endoplasmic reticulum and mitochondria in SK-N-SH cells. Cell Calcium 45, 340–345 (2009).